Acadia Healthcare (NASDAQ:ACHC) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Acadia Healthcare (NASDAQ:ACHC) announced its earnings results on Wednesday. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09, Zacks reports. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The business had revenue of $828.80 million for the quarter, compared to analyst estimates of $822.89 million. During the same quarter in the previous year, the firm posted $0.40 earnings per share. Acadia Healthcare’s revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare updated its Q2 2026 guidance to 0.300-0.400 EPS.

Acadia Healthcare Trading Up 2.5%

Shares of ACHC opened at $28.26 on Thursday. The company has a current ratio of 1.55, a quick ratio of 1.55 and a debt-to-equity ratio of 1.27. The stock has a market cap of $2.60 billion, a PE ratio of -2.32, a PEG ratio of 9.51 and a beta of 0.71. Acadia Healthcare has a 1 year low of $11.43 and a 1 year high of $28.57. The stock has a 50 day simple moving average of $24.25 and a 200-day simple moving average of $19.15.

Acadia Healthcare News Roundup

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Q1 results beat estimates — Acadia reported $0.37 EPS vs. the $0.28 consensus and revenue of $828.8M (up 7.6% YoY), showing underlying demand and margin improvement drivers. Acadia Healthcare (ACHC) Q1 Earnings and Revenues Beat Estimates
• Positive Sentiment: Revenue growth and management commentary — Same?facility revenue rose ~7.3% with stronger revenue per patient day and modest patient?day growth; the company highlighted operational momentum in its Q1 release. Acadia Healthcare Announces First Quarter 2026 Results
• Positive Sentiment: Notable investor interest — Coverage pieces point out a stake and endorsement by well?known value investors (David Einhorn references), which can attract longer?term investor attention. 5 Under-the-Radar Picks from David Einhorn…
• Neutral Sentiment: Company disclosures and materials available — Press release, slide deck and call materials were posted for investors to review the quarter and outlook. Q1 2026 Press Release / Slide Deck
• Negative Sentiment: Softer Q2 guidance vs. Street — Management set Q2 EPS of $0.30–$0.40 and revenue $835–$850M, both below analyst consensus (~$0.46 EPS and $867M revenue), which is the main near?term negative catalyst pressuring the stock. Acadia Healthcare Announces First Quarter 2026 Results
• Negative Sentiment: Leadership question — The appointment of an interim CFO drew coverage about leadership stability and execution risk as the company works to hit 2026 targets. Interim CFO Appointment Tests Acadia Healthcare Leadership Stability And 2026 Targets
• Negative Sentiment: EPS slightly down YoY and margin data — Q1 EPS was lower than the prior year ($0.37 vs. $0.40) and the company still reports a negative net margin, factors that underline remaining profitability and leverage concerns. Acadia Healthcare (ACHC) Stock Profile

Institutional Trading of Acadia Healthcare

A number of large investors have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Acadia Healthcare during the first quarter valued at $1,600,000. Goldman Sachs Group Inc. increased its position in shares of Acadia Healthcare by 21.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after purchasing an additional 121,444 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Acadia Healthcare by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock valued at $10,337,000 after purchasing an additional 27,207 shares during the last quarter. American Century Companies Inc. lifted its holdings in Acadia Healthcare by 531.5% during the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock valued at $2,399,000 after purchasing an additional 88,995 shares during the last quarter. Finally, Prudential Financial Inc. boosted its position in Acadia Healthcare by 21.9% in the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock valued at $225,000 after buying an additional 1,780 shares in the last quarter.

Wall Street Analyst Weigh In

ACHC has been the subject of a number of research analyst reports. Jefferies Financial Group reaffirmed a “hold” rating and set a $24.50 price objective on shares of Acadia Healthcare in a research report on Monday, April 20th. Zacks Research upgraded Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research note on Thursday, March 5th. TD Cowen raised their price objective on Acadia Healthcare from $24.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Finally, Guggenheim lowered their price objective on Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating on the stock in a research report on Monday, February 23rd. Seven investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $22.65.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.